Dov Elefant

2015 - Akari Therapeutics Plc

In 2015, Dov Elefant earned a total compensation of $1.1M as Chief Financial Officer at Akari Therapeutics Plc, a 397% increase compared to previous year.

Compensation breakdown

Bonus$37,500
Option Awards$857,879
Salary$200,000
Total$1,095,379

Elefant received $857.9K in option awards, accounting for 78% of the total pay in 2015.

Elefant also received $37.5K in bonus and $200K in salary.

Rankings

In 2015, Dov Elefant's compensation ranked 7,516th out of 13,638 executives tracked by ExecPay. In other words, Elefant earned more than 44.9% of executives.

ClassificationRankingPercentile
All
7,516
out of 13,638
45th
Division
Manufacturing
2,839
out of 5,187
45th
Major group
Chemicals And Allied Products
1,029
out of 1,857
45th
Industry group
Drugs
830
out of 1,531
46th
Industry
Pharmaceutical Preparations
649
out of 1,179
45th
Source: SEC filing on April 28, 2016.

Elefant's colleagues

We found three more compensation records of executives who worked with Dov Elefant at Akari Therapeutics Plc in 2015.

2015

Gur Roshwalb

Akari Therapeutics Plc

Chief Executive Officer

2015

Clive Richardson

Akari Therapeutics Plc

Chief Operating Officer

2015

Pablo Jimenez

Akari Therapeutics Plc

Chief Medical Officer

News

In-depth

You may also like